01—Abstract
Summary
Summary of the 8-K filed October 30, 2025. Cited figures are marked; the original filing is the authoritative source.
Motorola Solutions (MSI) reported record third-quarter 2025 results for the quarter ended September 27, 2025, with sales of $3.0 billiona (up 8% year over year, or about 3% organic after $123 million of acquisition revenue), GAAP EPS of $3.33 (up 1%), and non-GAAP EPS of $4.06 (up 9%).
Growth was broad-based: Products and Systems Integration sales rose 6% and Software and Services sales rose 11%. Non-GAAP operating margin expanded 80 basis points to 30.5%, and operating cash flow of $799 millionb and free cash flow of $733 million were both Q3 records. Record Q3 backlog reached $14.6 billion, although Products and Systems Integration backlog fell 14% on strong MCN shipments.
The quarter was dominated by the $4.4 billionc acquisition of Silvus Technologies, funded by $2.0 billion of senior notes, $1.5 billion of term loans, and roughly $900 million of cash and commercial paper. The deal lifted total debt and goodwill substantially (long-term debt rose to $8.4 billion from $5.7 billion at year-end 2024, and goodwill rose to $6.8 billion from $3.5 billion), and it drove higher interest expense and non-deductible transaction costs that pushed the GAAP tax rate to 22.2%. Management raised full-year 2025 non-GAAP EPS guidance to $15.09-$15.15 from $14.88-$14.98 and maintained revenue guidance of about $11.65 billion (7.7% growth).
Q4 guidance calls for roughly 11% revenue growth and non-GAAP EPS of $4.30d-$4.36. Investors should weigh several risks alongside the strong results.
Organic growth of 3% in the quarter is well below the reported 8%, Silvus integration and the higher leverage are new factors, tariffs continue to pressure costs, and a U.S. government shutdown that began October 1, 2025 could delay federal shipments. Non-GAAP results also exclude sizeable items, notably about $74 million of Hytera litigation gains in Q3 that were removed from non-GAAP earnings and roughly $94 million year to date, so the cash and gain profile of the Hytera matter should be watched alongside the reported figures.
02—Key points
Key Highlights
- Q3 sales of $3,009 million, up 8% YoY; organic revenue up 3% after excluding $123 million from acquisitions, with $21 million of FX tailwind
- Non-GAAP EPS of $4.06 (up 9%) versus GAAP EPS of $3.33 (up 1%); the gap reflects about $0.73 per share of after-tax adjustments, including share-based compensation and intangible amortization
- Record Q3 operating cash flow of $799 million and free cash flow of $733 million, up 5% and 4% respectively
- Software and Services sales up 11% with non-GAAP operating margin of 32.6%; Products and Systems Integration sales up 6% with non-GAAP operating margin of 29.3%
- Record Q3 backlog of $14.6 billion, up 3% YoY, though Products and Systems Integration backlog fell 14%
- Full-year 2025 non-GAAP EPS guidance raised to $15.09-$15.15 from $14.88-$14.98; revenue guidance maintained at about $11.65 billion
- Silvus acquisition ($4.4 billion) pushed long-term debt to $8.4 billion and goodwill to $6.8 billion, and lifted the GAAP effective tax rate to 22.2%
03—Questions
Frequently Asked Questions
How much of the 8% sales growth came from the Silvus acquisition rather than the core business?
Acquisitions contributed $123 million of the $219 million year-over-year sales increase. On an organic basis, revenue grew about 3% to $2,886 million, with foreign currency adding roughly $21 million, so underlying growth is considerably lower than the headline 8%.
Why did GAAP EPS grow only 1% while non-GAAP EPS grew 9%?
The gap comes mainly from non-GAAP exclusions of about $0.73 per share after tax. The largest items are share-based compensation ($0.43 pre-tax), intangible amortization ($0.39), and acquisition-related transaction fees ($0.33). These were partly offset by a $0.44 pre-tax gain from Hytera litigation that management also excluded from non-GAAP results. Acquisition costs and higher amortization from Silvus weighed on GAAP results this quarter.
How is the Silvus acquisition being funded, and how does it change the balance sheet?
The $4.4 billion purchase was funded with $2.0 billion of senior notes issued in Q2, $1.5 billion of new term loans, and about $900 million from cash on hand and commercial paper. Short-term borrowings rose to $928 million, long-term debt to $8.4 billion, and cash fell to $894 million from $2.1 billion at year-end 2024. Net interest expense for the quarter rose to $86 million from $58 million a year earlier.
What risks could affect the company's Q4 and full-year outlook?
Key risks include the U.S. government shutdown that began October 1, 2025, which may delay shipments and contract fulfillment for federal customers; ongoing tariff and supply chain volatility, which the company says it has largely mitigated so far; and integration risk from Silvus. The Hytera litigation also carries uncertainty, since a pending District Court ruling could determine whether roughly $70 million of royalties is paid into escrow or directly to the company.
04—Continue